MedPath

Kind Pharmaceuticals LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

9

Active:0
Completed:4

Trial Phases

2 Phases

Phase 1:3
Phase 2:6

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Phase 2
6 (66.7%)
Phase 1
3 (33.3%)

A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome

Phase 2
Not yet recruiting
Conditions
Myelodysplastic Syndromes
Interventions
First Posted Date
2024-03-12
Last Posted Date
2024-03-15
Lead Sponsor
Kind Pharmaceuticals LLC
Target Recruit Count
63
Registration Number
NCT06304103

A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia

Phase 2
Recruiting
Conditions
β -Thalassemia
Interventions
Drug: AND017 capsules
Drug: AND017 Placebo
First Posted Date
2024-03-08
Last Posted Date
2024-06-28
Lead Sponsor
Kind Pharmaceuticals LLC
Target Recruit Count
64
Registration Number
NCT06302491
Locations
🇨🇳

Nanfang Hospital Southern Medical University, Guangzhou, Guangdong, China

🇨🇳

Maoming People's Hospital, Maoming, Guangdong, China

🇨🇳

Liuzhou People's Hospital, Liuzhou, Guangxi, China

and more 2 locations

A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy

Phase 2
Not yet recruiting
Conditions
Cancer-Related Anemia
Interventions
First Posted Date
2023-10-10
Last Posted Date
2024-06-24
Lead Sponsor
Kind Pharmaceuticals LLC
Target Recruit Count
36
Registration Number
NCT06075043

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

Phase 2
Not yet recruiting
Conditions
Chemotherapy Induced Anemia
Interventions
First Posted Date
2023-10-10
Last Posted Date
2024-06-24
Lead Sponsor
Kind Pharmaceuticals LLC
Target Recruit Count
36
Registration Number
NCT06075030

A Study of AND017 to Treat Anemia in Chronic Kidney Disease Patients on Dialysis

Phase 2
Completed
Conditions
Renal Anemia
Interventions
Drug: AND017 capsules TIW
Drug: AND017 capsules QW
First Posted Date
2022-03-03
Last Posted Date
2024-06-28
Lead Sponsor
Kind Pharmaceuticals LLC
Target Recruit Count
175
Registration Number
NCT05265325
Locations
🇺🇸

US Renal Care - Pine Bluff, Pine Bluff, Arkansas, United States

🇺🇸

North America Research Institute, Riverside, California, United States

🇺🇸

Rocky Mountain Kidney Care, Lone Tree, Colorado, United States

and more 22 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.